GUIDANCE FOR FULL-YEAR 2025 } Group revenues expected in the range of € 840 m to € 880 m (FY 2024: € 797.0 m) } R&D expenditures are expected in a range of € 40 m to € 50 m (FY 2024: € 50.9 m) } Adjusted Group EBITDA1 is expected to reach € 30 m to € 50 m (FY 2024: € 22.6 m) OUTLOOK 2028 } Group revenues CAGR2024-2028 targeted to be in a range of 8 – 12% } Adj. EBITDA margin 2028 expected to be above 20%
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。